Please login to the form below

Not currently logged in
Email:
Password:

product withdrawal

This page shows the latest product withdrawal news and features for those working in and with pharma, biotech and healthcare.

Fertility drugs drive healthcare growth at Merck KGaA

Fertility drugs drive healthcare growth at Merck KGaA

The company put the performance in the quarter down to the withdrawal of a rival product - Ferring's Bravelle - from the US market last year because of quality issues, as well

Latest news

  • Teva suspends migraine patch on burn reports Teva suspends migraine patch on burn reports

    In addition to the suspension from sale, Teva is also carrying out a pharmacy level recall of Zecuity and patients are recommended to stop using the product straight away.

  • Vioxx 'risks can be immediate'

    its global withdrawal of the product (September 2004) when the cardiovascular side effects became apparent and supported by scientific evidence.

  • Communicable risk

    product for which there is a reasonable possibility that the product caused a response. ... to take urgent measures (product withdrawal from the market), and assessment of product risk via life cycle management.

  • Risk nationale

    Many risk management interventions were designed and implemented in reaction to new safety information, mainly in an attempt to avoid product withdrawal. ... To obtain marketing approval, firms have to provide evidence that the product is both

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Brexit implications for UK pharma legislation Brexit implications for UK pharma legislation

    on certification of clinical trials, conformity with good manufacturing practices, manufacturing inspections and, in a most ambitious deal, on product licences. ... In due course, the UK could endeavour to reach equivalence and mutual recognition

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Real world project management

    The ex-trial patients were allowed to continue access free of charge until the product was commercially available in their country. ... In contrast to this is a programme we are managing to support the global withdrawal of an oncology product.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics